These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23733394)

  • 1. Guanidine hydrochloride denaturation of dopamine-induced α-synuclein oligomers: a small-angle X-ray scattering study.
    Pham CL; Kirby N; Wood K; Ryan T; Roberts B; Sokolova A; Barnham KJ; Masters CL; Knott RB; Cappai R; Curtain CC; Rekas A
    Proteins; 2014 Jan; 82(1):10-21. PubMed ID: 23733394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure of dopamine induced alpha-synuclein oligomers.
    Rekas A; Knott RB; Sokolova A; Barnham KJ; Perez KA; Masters CL; Drew SC; Cappai R; Curtain CC; Pham CL
    Eur Biophys J; 2010 Sep; 39(10):1407-19. PubMed ID: 20309679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner.
    Pham CL; Leong SL; Ali FE; Kenche VB; Hill AF; Gras SL; Barnham KJ; Cappai R
    J Mol Biol; 2009 Apr; 387(3):771-85. PubMed ID: 19361420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-terminal residues 43 to 60 form the interface for dopamine mediated α-synuclein dimerisation.
    Leong SL; Hinds MG; Connor AR; Smith DP; Illes-Toth E; Pham CL; Barnham KJ; Cappai R
    PLoS One; 2015; 10(2):e0116497. PubMed ID: 25679387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review on the interactions between dopamine metabolites and α-Synuclein in causing Parkinson's disease.
    Sivakumar P; Nagashanmugam KB; Priyatharshni S; Lavanya R; Prabhu N; Ponnusamy S
    Neurochem Int; 2023 Jan; 162():105461. PubMed ID: 36460239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of DNA aptamers that recognize α-synuclein oligomers using a competitive screening method.
    Tsukakoshi K; Abe K; Sode K; Ikebukuro K
    Anal Chem; 2012 Jul; 84(13):5542-7. PubMed ID: 22697251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation.
    Leong SL; Pham CL; Galatis D; Fodero-Tavoletti MT; Perez K; Hill AF; Masters CL; Ali FE; Barnham KJ; Cappai R
    Free Radic Biol Med; 2009 May; 46(10):1328-37. PubMed ID: 19248830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.
    Hansen C; Li JY
    Trends Mol Med; 2012 May; 18(5):248-55. PubMed ID: 22503115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facile "stop codon" method reveals elevated neuronal toxicity by discrete S87p-α-synuclein oligomers.
    Ha Y; Yang A; Lee S; Kim K; Liew H; Suh YH; Park HS; Churchill DG
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1085-91. PubMed ID: 24380864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells.
    Yamakawa K; Izumi Y; Takeuchi H; Yamamoto N; Kume T; Akaike A; Takahashi R; Shimohama S; Sawada H
    Biochem Biophys Res Commun; 2010 Jan; 391(1):129-34. PubMed ID: 19900407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of alpha-synuclein fibrillization by dopamine analogs via reaction with the amino groups of alpha-synuclein. Implication for dopaminergic neurodegeneration.
    Li HT; Lin DH; Luo XY; Zhang F; Ji LN; Du HN; Song GQ; Hu J; Zhou JW; Hu HY
    FEBS J; 2005 Jul; 272(14):3661-72. PubMed ID: 16008565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway.
    Cappai R; Leck SL; Tew DJ; Williamson NA; Smith DP; Galatis D; Sharples RA; Curtain CC; Ali FE; Cherny RA; Culvenor JG; Bottomley SP; Masters CL; Barnham KJ; Hill AF
    FASEB J; 2005 Aug; 19(10):1377-9. PubMed ID: 15946991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein oligomers and fibrils originate in two distinct conformer pools: a small angle X-ray scattering and ensemble optimisation modelling study.
    Curtain CC; Kirby NM; Mertens HD; Barnham KJ; Knott RB; Masters CL; Cappai R; Rekas A; Kenche VB; Ryan T
    Mol Biosyst; 2015 Jan; 11(1):190-6. PubMed ID: 25352253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High stability and cooperative unfolding of α-synuclein oligomers.
    Paslawski W; Andreasen M; Nielsen SB; Lorenzen N; Thomsen K; Kaspersen JD; Pedersen JS; Otzen DE
    Biochemistry; 2014 Oct; 53(39):6252-63. PubMed ID: 25216651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of Dopamine to Alpha-Synuclein is Mediated by Specific Conformational States.
    Illes-Toth E; Dalton CF; Smith DP
    J Am Soc Mass Spectrom; 2013 Sep; 24(9):1346-54. PubMed ID: 23817832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-Synuclein Fibrils Interact with Dopamine Reducing its Cytotoxicity on PC12 Cells.
    Khalife M; Morshedi D; Aliakbari F; Tayaranian Marvian A; Mohammad Beigi H; Azimzadeh Jamalkandi S; Pan-Montojo F
    Protein J; 2015 Aug; 34(4):291-303. PubMed ID: 26250981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.
    Di Pasquale E; Fantini J; Chahinian H; Maresca M; Taïeb N; Yahi N
    J Mol Biol; 2010 Mar; 397(1):202-18. PubMed ID: 20114052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.